Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Ethylene oxide in blood of ethylene-exposed B6C3F1 mice, Fischer 344 rats, and humans.
Toxicol. Sci. 136, 344-358 (2013)
The gaseous olefin ethylene (ET) is metabolized in mammals to the carcinogenic epoxide ethylene oxide (EO). Although ET is the largest volume organic chemical worldwide, the EO burden in ET-exposed humans is still uncertain, and only limited data are available on the EO burden in ET-exposed rodents. Therefore, EO was quantified in blood of mice, rats, or 4 volunteers that were exposed once to constant atmospheric ET concentrations of between 1 and 10 000 ppm (rodents) or 5 and 50 ppm (humans). Both the compounds were determined by gas chromatography. At ET concentrations of between 1 and 10 000 ppm, areas under the concentration-time curves of EO in blood (µmol × h/l) ranged from 0.039 to 3.62 in mice and from 0.086 to 11.6 in rats. At ET concentrations ≤ 30 ppm, EO concentrations in blood were 8.7-fold higher in rats and 3.9-fold higher in mice than that in the volunteer with the highest EO burdens. Based on measured EO concentrations, levels of EO adducts to hemoglobin and lymphocyte DNA were calculated for diverse ET concentrations and compared with published adduct levels. For given ET exposure concentrations, there were good agreements between calculated and measured levels of adducts to hemoglobin in rats and humans and to DNA in rats and mice. Reported hemoglobin adduct levels in mice were higher than calculated ones. Furthermore, information is given on species-specific background adduct levels. In summary, the study provides most relevant data for an improved assessment of the human health risk from exposure to ET.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
4.328
1.385
5
6
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Ethylene ; Ethylene Oxide ; Mouse ; Rat ; Human ; Blood ; Hemoglobin Adducts ; Dna Adducts; Drug-metabolizing-enzymes; Cancer-risk Assessment; Hemoglobin Adducts; Dna-adducts; In-vivo; Propylene-oxide; Endogenous Production; Inhalation Exposure; Molecular Dosimetry; Alkylating-agents
Sprache
englisch
Veröffentlichungsjahr
2013
HGF-Berichtsjahr
2013
ISSN (print) / ISBN
1096-6080
e-ISSN
1096-0929
Zeitschrift
Toxicological Sciences
Quellenangaben
Band: 136,
Heft: 2,
Seiten: 344-358
Verlag
Oxford University Press
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-505200-002
G-505200-003
G-505200-003
PubMed ID
24068676
WOS ID
WOS:000328695500007
Scopus ID
84890418523
Erfassungsdatum
2013-12-04